AAAAAA
Results:
1-7
|
Results: 7
Authors:
Forslund, A
Kressner, U
Lindmark, G
Inganas, M
Lundholm, K
Citation: A. Forslund et al., Serum anti-p53 in relation to mutations across the entire translated p53 gene in colorectal carcinomas, INT J ONCOL, 19(3), 2001, pp. 501-506
Authors:
Inganas, M
Byding, S
Eckersten, A
Eriksson, S
Hultman, T
Jorsback, A
Lofman, E
Sabounchi, F
Kressner, U
Lindmark, G
Tooke, N
Citation: M. Inganas et al., Enzymatic mutation detection in the P53 gene, CLIN CHEM, 46(10), 2000, pp. 1562-1573
Authors:
Berns, EMJJ
Foekens, JA
Vossen, R
Look, MP
Devilee, P
Henzen-Logmans, SC
van Staveren, IL
van Putten, WLJ
Inganas, M
Meijer-van Gelder, ME
Cornelisse, C
Claassen, CJC
Portengen, H
Bakker, B
Klijn, JGM
Citation: Emjj. Berns et al., Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer, CANCER RES, 60(8), 2000, pp. 2155-2162
Authors:
Dorum, A
Hovig, E
Trope, C
Inganas, M
Moller, P
Citation: A. Dorum et al., Three per cent of Norwegian ovarian cancers are caused by BRCA1 1675delA or 1135insA, EUR J CANC, 35(5), 1999, pp. 779-781
Authors:
Kressner, U
Inganas, M
Byding, S
Blikstad, I
Pahlman, L
Glimelius, B
Lindmark, G
Citation: U. Kressner et al., Prognostic value of p53 genetic changes in colorectal cancer, J CL ONCOL, 17(2), 1999, pp. 593-599
Authors:
Dorum, A
Heimdal, K
Hovig, E
Inganas, M
Moller, P
Citation: A. Dorum et al., Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer, AM J HU GEN, 65(3), 1999, pp. 671-679
Authors:
Brattstrom, D
Bergqvist, M
Lamberg, K
Kraaz, W
Scheibenflug, L
Gustafsson, G
Inganas, M
Wagenius, G
Brodin, O
Citation: D. Brattstrom et al., Complete sequence of p53 gene in 20 patients with lung cancer: comparison with chemosensitivity and immunohistochemistry, MED ONCOL, 15(4), 1998, pp. 255-261
Risultati:
1-7
|